| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Revenue | $331.5M | +12.6% |
| Cost of Revenue | $87.2M | -8.3% |
| Gross Profit | $244.3M | +22.6% |
| R&D Expense | $121.6M | -1.4% |
| SG&A Expense | $52.5M | -9.4% |
| Operating Income | -$579.9M | -2032.2% |
| Interest Expense | $12.6M | -15.0% |
| Pre-tax Income | -$584.6M | -1506.6% |
| Income Tax | $3.5M |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Short-term Investments | $5.5M | -40.3% |
| Accounts Receivable | $62.8M | +2.4% |
| Inventory | $1.0M | +100.0% |
| Current Assets | $265.5M | +17.6% |
| Total Assets | $702.4M | -45.9% |
| Current Liabilities | $216.8M | +46.4% |
| Long-term Debt | $281.9M | +2.2% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $17.2M | +129.3% |
| Capital Expenditures | $5.0M | -2.5% |
| Investing Cash Flow | $4.4M | -24.8% |
| Financing Cash Flow | $225K | +104.2% |
| Free Cash Flow | $12.2M | +413.9% |
| -82.5% |
| Net Income | -$588.1M | -945.4% |
| EPS (Basic) | -$14.12 | -908.6% |
| EPS (Diluted) | -$14.12 | -908.6% |
| Total Liabilities |
| $561.3M |
| -6.9% |
| Stockholders' Equity | $141.1M | -79.7% |